Administration of Blood and Blood Products (LO4) Flashcards

1
Q

Blood serves the following functions:

A

Supplies oxygen and nutrients for energy production and for tissue maintenance, growth, and repair

Transports cellular waste, including carbon dioxide, to the organs for elimination

Provides a defense against infection by transporting antibodies

Regulates and equalizes body temperature

Helps to maintain the acid-base balance

Regulates fluid and electrolyte balance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Blood is made up of 2 basic components:

A

Cellular or formed elements

Plasma 

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Plasma

A

is a sticky straw-coloured fluid

approximately 90% water.

Dissolved within the plasma are over 100 different solutes including proteins, nutrients, electrolytes, and respiratory gases.

Plasma makes up about 55% of the volume of blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Erythrocytes

A

(red blood cells)

constitute approximately 45% of the blood’s volume

have a dedicated role in the transportation of respiratory gases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Leukocytes

A

white blood cells

make up less than 1% of the entire blood volume

play a major role in defense against infection and disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Platelets

A

(also less than 1% of blood volume)

are necessary for the clotting process and circulate in the vasculature, inactive until a blood vessel ruptures or is damaged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Blood is group classified based

A

on the types of antigens present or absent on the surfaces of the red blood cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pre-transfusion testing includes the following

A

Blood typing

Antibody detection (and antibody identification if antibody screen is positive)

Crossmatching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ABO Group

  • A
  • B
  • AB
  • O
  • name antigen and the frequency in population
A

-A
40%

-B
11%

-A and B
4%

-None
45%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A patient’s antibodies will do what to red blood cells that have corresponding antigen on their surface

A

A patient’s antibodies will hemolyze (break down or destroy red blood cells) transfused red blood cells that have the corresponding antigen on their surface.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Historically, patients whose blood group was unknown and who required an urgent transfusion were provided with

A

Group O Rh negative red blood cells (RBC) until the patient’s blood group was determined

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In situations where the blood group is unknown:

A

The Transfusion Medicine Laboratory (TML) will usually issue O Rh negative RBC’s for females of child bearing potential (less than 45 years of age) until the patient’s blood group is confirmed.

All males and females past child bearing potential, can receive O Rh positive RBC’s until the patient’s blood group is confirmed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Crossmatching 

A

is the process of determining the compatibility of blood from a donor with that of the recipient before transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Whole blood 

A

contains all components of blood

the clotting factors and platelets quickly lose their function during storage

A unit contains approximately 450 mL of whole blood plus 63 mL of anticoagulant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Indications of whole blood

A

indicated in blood loss

not commonly available from blood banks, and therefore red blood cells are more commonly used for treatment of anemia and acute blood loss

One unit of whole blood can increase the patient’s hemoglobin by approximately 10g/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Infusion Rate of whole blood

A

The initial transfusion should be slow (5 mL/min for 15 minutes) while assessing the patient for adverse reactions

In the absence of any reactions, the product can be infused as quickly as the patient can tolerate it. 

The transfusion must be completed with the 4-hour window

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

whole blood Compatibility

A

Normal saline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

whole blood Special Considerations

A

Whole blood must be ABO-identical to the recipient’s blood group. (Group O is not universal donor for whole blood.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

whole blood Administration Set

A

The administration set must be a blood tubing set that has a 170–260 micron blood filter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

whole blood Storage and Shelf Life

A

Whole blood cannot be left at room temperature for longer than 4 hours.

As soon as collection from the donor is complete, whole blood must be stored at 1–6° C
the red blood cells will retain their function for up to 21–35 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Whole Blood – Overview

  • major uses
  • storage and shelf life
  • administration
A

Major Uses

  • To replace:
  • Fibrinogen: in patients actively bleeding who have a low fibrinogen level

Storage and Expiration

  • Frozen
  • Shelf life: 1 year
  • Once thawed, expires after 4 hours stored at 20–24°C

Administration

  • Blood tubing required
  • Transfuse as rapidly as tolerated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Red Blood Cells

A

along with normal saline are more commonly used than whole blood for acute blood loss

A unit of red blood cells is 240–340 mL and will be more viscous than whole blood
most red blood cell components today have an additive solution mixed with the red blood cells (e.g., AS-3).

With an additive solution, red blood cells will have the same flow rate as whole blood
Red blood cells have minimal amounts of plasma (and ABO antibodies) so you can give ABO-compatible blood rather than only ABO identical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Red Blood Cells indications

A

Red blood cells units are administered to patients requiring increased oxygen-carrying capacity by increasing the circulating red blood cell mass.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Infusion Rate

A

The initial infusion should be slow for the first 15 minutes to assess for adverse reactions, then administered as quickly as the patient tolerates

A slower rate should be considered for patients at risk for overload.

A unit of red blood cells must be administered within 4 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

red blood cells Compatibility

A

Normal Saline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

red blood cells special considerations

A

In massive transfusions, if possible warm blood with approved blood warmer prior to transfusion to prevent hypothermia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

cAdministration Set

A

The administration set must be a blood tubing set that has a 170–260 micron blood filter.

If administering at a fast rate, 16–18 gauge cathlon is required

in small vein patients a 20–22 gauge may be used. 

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

red blood cells shelf life

A

Depending on the anticoagulant and additive solution used, red blood cell units have a shelf life of 21–42 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

red blood cells Storage

A

Red blood cells must be stored at 2–6° C. During inter-facility transfers, the blood should be stored in a Canadian Blood Services styrofoam box with ice packs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Red Blood Cells – Overview

A

Major Uses

  • Bleeding or anemic non-bleeding patients with signs and symptoms of impaired tissue oxygen delivery:
  • -Tachycardia
  • -Shortness of breath
  • -Dizziness

Storage and Expiration
-2–6° C in approved refrigerator only
  -Shelf life: Maximum 42 days

Administration

  • Blood tubing required
  • Initiate transfusion slowly for first 15 minutes unless massive blood loss
  • Transfuse over no more than 4 hours
  • Typically over 1½–2 hours with slower rates for patients at risk for circulatory overload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Fresh Frozen Plasma

A
  • Fresh frozen plasma (FFP) is separated from whole blood by centrifugation or sedimentation and must be frozen within 8 hours of collection
  • A unit of fresh frozen plasma (FFP) contains approximately 250 mL (minimum 100 mL) of anticoagulated plasma.  
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Fresh Frozen Plasma Indications

A

Fresh frozen plasma (FFP) is separated from whole blood by centrifugation or sedimentation and must be frozen within 8 hours of collection

A unit of fresh frozen plasma (FFP) contains approximately 250 mL (minimum 100 mL) of anticoagulated plasma.  

Fresh frozen plasma is indicated for patients requiring plasma coagulation factors, patients on Coumadin requiring emergency invasive procedures before Vitamin K can reverse its effects, or patients with plasma protein deficiencies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Infusion Rate Fresh Frozen Plasma

A

Recommended infusion time is 30 minutes to 120 minutes but must be infused within 4 hours. 

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Compatibility Fresh Frozen Plasma

A

Normal Saline

35
Q

Special Considerations Fresh Frozen Plasma

A

FFP should be thawed in a water bath at 30–37° C (in a watertight protective plastic over wrap using gentle agitation); this may take 20–30 minutes.

Once thawed, FFP must be used immediately and cannot be refrozen.

36
Q

Administration Set

A

The administration set must be a blood tubing set that has a 170–260 micron blood filter.

37
Q

Storage and Shelf Life

A

FFP can be stored up to 12 months at temperatures -18° C and for 24 hours at 1–6° C once thawed.

38
Q

Fresh Frozen Plasma – Overview

A
Major Uses 
-Liver disease coagulopathy 
--Massive transfusion 
--Plasma exchange procedures for certain diseases (e.g., TTP/HUS*) 
Frozen 

Storage and Expiration
-Shelf life: 1 year; Once thawed, expires after 5 days stored at 1–6° C

Administration 
-Blood tubing required 
Initiate transfusion slowly for first 15 minutes unless massive blood loss 
-Transfuse over no more than 4 hours 
-Typically over 30 minutes–2 hours
39
Q

Cryoprecipitate

A

produced by Canadian Blood Services from fresh frozen plasma

An insoluble precipitate, cryoprecipitate, is separated from the plasma and refrozen

One unit of cryoprecipitate contains 80IU of Factor VIII and 150 mg of fibrinogen in 5–15 mL of plasma.  

40
Q

Indications of cryoprecipitate

A

Cryoprecipitate is indicated in patients requiring a source of fibrinogen or Factor VIII.

It can only be used as a source of Factor VIII when virally inactivated fractionation products or recombinant Factor VIII (used for Hemophilia A) are not available.

41
Q

Infusion Rate of cryoprecipitate

A

Recommended infusion time is 10–30 minutes per dose but must be complete within 4 hours. 

42
Q

Compatibility of cryoprecipitate

A

Normal saline

43
Q

Administration Set of cryoprecipitate

A

The administration set must be a blood tubing set that has a 170–260 micron blood filter.

44
Q

Storage and Shelf Life

A

Cryoprecipitate can be stored up to 12 months at temperatures of -18° C and for 4 hours at 20-24° C.

45
Q

Cryoprecipitate – Overview

A

Major Uses

  • To replace:
  • Fibrinogen: in patients actively bleeding who have a low fibrinogen level

Storage and Expiration

  • Frozen
  • Shelf life: 1 year; Once thawed, expires after 5 days stored at 1–6° C

Administration

  • Blood tubing required
  • Transfuse as rapidly as tolerated
46
Q

4.1 Rights of Transfusion

A
  1. Patient - Is this the right patient?
  2. Product - Is this the right product?

Check the blood for any clots, leaks, or discolouration

Check the expiry date

  1. Amount - Is this the right amount?
  2. Rate - Is it set at the right rate?
  3. Time - Is it the right time?
47
Q

monitoring of a patient receiving blood products:

A

Only transport those patients receiving blood products that have been  stable for last 24 hours

Ensure that vital sign assessment is performed 15 minutes after the initiation of transfusion

Repeat vitals every 30 minutes, including a temperature

Repeat vitals more often for patients who are at greater risk of overload or experienced previous reactions

Ensure that a physician’s order is present specifying the infusion rate and that the rate is no faster than 2 hours per unit

All infusions must be complete within 4 hours of initiation

A pressure infuser cannot be utilized unless a physician is present during transport

Only normal saline can be infused through the same IV line as a blood product

All blood tubing must be changed every 2–4 units of blood

48
Q

Steps Upon Completion of Transfusion

A

Disconnect blood tubing once infusion is complete, as used tubing can be a breeding ground for bacteria

Dispose of used blood tubing and bags in a biohazard bag and return to the hospital

Continue to assess patient for symptoms of reactions for 6 hours post transfusion

49
Q

Documentation

A

include the following on your PCR:

Start and finish time of each bag

Type of product being infused

Blood unit number

Rate the transfusion was run at

Volume transfused during transport

Vital signs and assessment findings

Any reactions and treatment provided

50
Q

List Potential Complications of Blood and Blood Product Transfusions

A

Adverse effects, generally referred to as transfusion reactions, are infrequent and vary in severity.

Death due to transfusion is rare

AIDS has occurred following transfusion, but blood donors are now tested

51
Q

Adverse reactions can be classified as one of the following:

A

Immediate transfusion reactions

Delayed transfusion reactions

52
Q

deaths from blood transfusion

A

The majority of deaths are due to severe intravascular hemolysis (the destruction of red blood cells) following the administration of ABO mismatched blood

Viral hepatitis is the second most common cause of death related to blood transfusion; the association with transfusion may not be recognized, and the hepatitis may develop many months after the transfusion

53
Q

Immediate Transfusion Reactions

A

Reactions that occur during or within 24 hours of the infusion of blood products

They include the following: 
Acute hemolytic transfusion reactions 
Febrile reactions 
Allergic reactions 
Air embolism 
Overload 
Chills 
Hypothermia
54
Q

Acute Hemolytic Transfusion Reactions

A

rare

usually due to the transfusion of ABO incompatible blood following the improper identification of the recipient, either when the crossmatch specimen is taken or when the blood donor is transfused

55
Q

Signs of acute intravascular hemolysis include

A

fever, chills, hypotension, hemoglobinuria (the presence of hemoglobin in the urine which may cause a reddish discoloration of the urine), flank pain, and shortness of breath

56
Q

disseminated intravascular coagulation (DIC)

A

results in abnormal bleeding such as around an IV site

57
Q

Febrile Reactions

A

during transfusion is the most common adverse reaction following a transfusion

58
Q

Febrile Reactions may be due to

A

Destruction of transfused red blood cells

Destruction of transfused white blood cells

Bacterial contamination of the blood

Reaction to proteins

59
Q

Urticaria during blood transfusion

A

(hives)

fairly common. Unless extremely severe or accompanied by bronchospasm or other signs of impending anaphylaxis, the development of urticaria is not serious

Treatment consists of discontinuing the transfusion of the blood product and keeping the IV line open with normal saline.

60
Q

Anaphylaxis

A

A life-threatening anaphylactic reaction (hypotension, bronchospasm, flushing, and laryngeal edema) rarely occurs during a transfusion of blood

Treatment consists of discontinuing the transfusion of the blood product, keeping the IV line open with normal saline, providing high flow O2, etc.

61
Q

Air Embolism

A

The use of closed plastic systems for the collection of whole blood and for the preparation of blood components has virtually eliminated air embolism as a complication of blood transfusion

deaths have occurred when air has been deliberately introduced into the blood bag, or the administration set, to increase the rate of blood flow to the patient

62
Q

Delayed Transfusion Reactions

A

a delayed reaction occurs after 24 hours and in some cases is not identified until much later.

63
Q

Delayed Transfusion Reactions include

A

Hepatitis

Sepsis

Iron overload

Delayed hemolytic reaction

Post transfusion purpura

Transfusion-associated graft-versus-host disease

64
Q

Transfusion Associated Circulatory Overload (TACO)

A

The infusion of blood products can cause fluid overload and resultant pulmonary edema

Circulatory overload occurs when the rate of infusion is excessive for that patient’s cardiovascular status especially in the elderly or very young

65
Q

Transfusion Associated Circulatory Overload (TACO) symptom

A

These patients complain of shortness of breath (which can also be present with anaphylactic and acute hemolytic reactions)

66
Q

Transfusion Associated Circulatory Overload (TACO) treatment

A

Treatment consists of discontinuing the transfusion of the blood product and keeping the IV line open with normal saline

The patient should also be placed on high flow O2 and placed as high as possible in the sitting position.

67
Q

Chills and treatment

A

Chills may occur as a result of a febrile reaction or in patients with a normal temperature

In either case the transfusion should be discontinued

Treatment consists of discontinuing the transfusion of the blood product and keeping the IV line open with normal saline

68
Q

Hypothermia and treatment

A

Hypothermia may occur if cold blood is rapidly transfused

Treatment consists of discontinuing the transfusion of the blood product and keeping the IV line open with normal saline

69
Q

Possible Transfusion Reaction

-Fever, chills, or rigors (shaking)

A

Bacterial contamination

Acute hemolytic transfusion reaction

Transfusion related acute lung injury (TRALI)

Febrile non-hemolytic transfusion reaction

70
Q

Possible Transfusion Reaction

-Urticaria and other allergic symptoms

A

Anaphylaxis

Minor allergic reaction

71
Q

Possible Transfusion Reaction

-dyspnea

A

Transfusion related acute lung injury (TRALI)

Transfusion associated circulatory overload (TACO)

Anaphylaxis

Bacterial contamination

Acute hemolytic transfusion reaction

72
Q

Possible Transfusion Reaction

-Hypotension

A

Transfusion associated circulatory overload (TACO)

73
Q

Possible Transfusion Reaction

-Hemolysis, hemoglobinuria

A

Acute hemolytic transfusion reaction

74
Q

Possible Transfusion Reaction

-Pain

A

Acute hemolytic transfusion reaction

IV site

Lumbar

Transfusion associated circulatory overload (TACO)

Chest

75
Q

Possible Transfusion Reaction

-Nausea and vomiting

A

Acute hemolytic transfusion reaction

Acute anaphylaxis

Febrile non-hemolytic transfusion reaction

76
Q

Risk and Description

-Minor Allergic Reaction

A

1 in 100

Mild allergic reaction to an allergen in the blood component/product.

77
Q

Risk and Description

-Anaphylaxis

A

1 in 40,000

Potentially fatal reaction caused by an allergen that the patient has been sensitized to.

78
Q

Risk and Description

-Febrile Non-Hemolytic Transfusion Reaction

A

1 in 300

Mild, usually self-limiting, reaction associated with donor white blood cells or cytokines in the blood component/product. Usually presents with fever and/or rigors.

79
Q

Risk and Description

-Bacterial Sepsis (platelet pool)

A

1 in 10,000 will become symptomatic
1 in 60,000 will be fatal

Potentially fatal reaction caused by bacteria inadvertently introduced into the blood component/product or originating from the donor. More common in platelets due to room temperature storage.

80
Q

Risk and Description

-Bacterial Sepsis (red blood cells)

A

1 in 250,000 will become symptomatic
1 in 500,000 will be fatal

More common in platelets due to room temperature storage.

81
Q

Risk and Description

-Acute Hemolytic Transfusion Reaction

A

1 in 40,000
Potentially fatal reaction caused by blood group incompatibility.

Can also be caused by chemical hemolysis 
(e.g. incompatible solutions) or mechanical hemolysis (e.g. improper storage).

Can result in renal failure, shock, and coagulopathy.

82
Q

Risk and Description

-Transfusion Related Acute Lung Injury (TRALI)

A

1 in 12,000

Acute hypoxemia with evidence of new bilateral lung infiltrates on X-ray and no evidence of circulatory overload.

Patients often require ventilatory support.

Usually occurs within 1–2 hours of start of transfusion and rarely after 6 hours.

Usually resolves within
24–72 hours, with death occurring in 5–10%. Cause not fully understood.
Postulated to be related to donor or recipient antibodies acquired through pregnancy or transfusion.

83
Q

Risk and Description

-Transfusion Associated Circulatory Overload (TACO)

A

1 in 100

Circulatory overload from excessively rapid transfusion and/or in patients at greater risk for overload (e.g. very young, elderly, impaired cardiac function). Preventative measures include slower transfusion rates and pre-emptive diuretics for patients at risk.

84
Q

Risk and Description

-Hypotensive Reaction

A

Rare

Bradykinin mediated hypotension.

Characterized by profound drop in blood pressure, usually seen in patients on ACE inhibitors unable to degrade bradykinin in blood component/product.